| UniProt ID | NAKD2_HUMAN | |
|---|---|---|
| UniProt AC | Q4G0N4 | |
| Protein Name | NAD kinase 2, mitochondrial | |
| Gene Name | NADK2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 442 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | Mitochondrial NAD(+) kinase that phosphorylates NAD(+) to yield NADP(+). Can use both ATP or inorganic polyphosphate as the phosphoryl donor. Also has weak NADH kinase activity in vitro; however NADH kinase activity is much weaker than the NAD(+) kinase activity and may not be relevant in vivo.. | |
| Protein Sequence | MTCYRGFLLGSCCRVAGGRAAALRGPGAGGPAARPRLGGDGGGRRHLGQGQPRELAGCGSRADGGFRPSRVVVVAKTTRYEFEQQRYRYAELSEEDLKQLLALKGSSYSGLLERHHIHTKNVEHIIDSLRNEGIEVRLVKRREYDEETVRWADAVIAAGGDGTMLLAASKVLDRLKPVIGVNTDPERSEGHLCLPVRYTHSFPEALQKFYRGEFRWLWRQRIRLYLEGTGINPVPVDLHEQQLSLNQHNRALNIERAHDERSEASGPQLLPVRALNEVFIGESLSSRASYYEISVDDGPWEKQKSSGLNLCTGTGSKAWSFNINRVATQAVEDVLNIAKRQGNLSLPLNRELVEKVTNEYNESLLYSPEEPKILFSIREPIANRVFSSSRQRCFSSKVCVRSRCWDACMVVDGGTSFEFNDGAIASMMINKEDELRTVLLEQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 76 | 2-Hydroxyisobutyrylation | SRVVVVAKTTRYEFE CEEEEEEECCCHHHH | - | ||
| 76 | Acetylation | SRVVVVAKTTRYEFE CEEEEEEECCCHHHH | - | ||
| 76 | Malonylation | SRVVVVAKTTRYEFE CEEEEEEECCCHHHH | 26320211 | ||
| 76 | Succinylation | SRVVVVAKTTRYEFE CEEEEEEECCCHHHH | - | ||
| 76 | Succinylation | SRVVVVAKTTRYEFE CEEEEEEECCCHHHH | - | ||
| 93 | Phosphorylation | RYRYAELSEEDLKQL HHHHHHCCHHHHHHH | - | ||
| 98 | Acetylation | ELSEEDLKQLLALKG HCCHHHHHHHHHHCC | 23954790 | ||
| 98 | Ubiquitination | ELSEEDLKQLLALKG HCCHHHHHHHHHHCC | - | ||
| 104 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 104 (in isoform 1) | Ubiquitination | - | 21890473 | ||
| 104 | Ubiquitination | LKQLLALKGSSYSGL HHHHHHHCCCCHHHH | 21890473 | ||
| 106 | Phosphorylation | QLLALKGSSYSGLLE HHHHHCCCCHHHHHH | 24275569 | ||
| 109 | Phosphorylation | ALKGSSYSGLLERHH HHCCCCHHHHHHHCC | 27499020 | ||
| 170 | Ubiquitination | TMLLAASKVLDRLKP HHHHHHHHHHHHCCC | - | ||
| 176 (in isoform 3) | Ubiquitination | - | 21906983 | ||
| 176 | Ubiquitination | SKVLDRLKPVIGVNT HHHHHHCCCCCCCCC | - | ||
| 183 | Phosphorylation | KPVIGVNTDPERSEG CCCCCCCCCCCCCCC | 20166139 | ||
| 188 | Phosphorylation | VNTDPERSEGHLCLP CCCCCCCCCCEEEEE | 24972180 | ||
| 198 | Phosphorylation | HLCLPVRYTHSFPEA EEEEEEEEECCCHHH | 24719451 | ||
| 201 | Phosphorylation | LPVRYTHSFPEALQK EEEEEECCCHHHHHH | 24719451 | ||
| 210 | Phosphorylation | PEALQKFYRGEFRWL HHHHHHHHHHCHHHH | 24719451 | ||
| 283 | Phosphorylation | NEVFIGESLSSRASY CEEEECCCCCCCCCE | 21815630 | ||
| 289 | Phosphorylation | ESLSSRASYYEISVD CCCCCCCCEEEEECC | 24275569 | ||
| 294 | Phosphorylation | RASYYEISVDDGPWE CCCEEEEECCCCCHH | - | ||
| 302 | Ubiquitination | VDDGPWEKQKSSGLN CCCCCHHHCCCCCCE | - | ||
| 302 | Succinylation | VDDGPWEKQKSSGLN CCCCCHHHCCCCCCE | - | ||
| 302 | Succinylation | VDDGPWEKQKSSGLN CCCCCHHHCCCCCCE | - | ||
| 304 | Ubiquitination | DGPWEKQKSSGLNLC CCCHHHCCCCCCEEC | - | ||
| 304 | Succinylation | DGPWEKQKSSGLNLC CCCHHHCCCCCCEEC | 27452117 | ||
| 304 | Malonylation | DGPWEKQKSSGLNLC CCCHHHCCCCCCEEC | 26320211 | ||
| 307 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 312 | Phosphorylation | SSGLNLCTGTGSKAW CCCCEECCCCCCCHH | 22468782 | ||
| 314 | Phosphorylation | GLNLCTGTGSKAWSF CCEECCCCCCCHHEE | 22468782 | ||
| 316 | Phosphorylation | NLCTGTGSKAWSFNI EECCCCCCCHHEEEH | 22468782 | ||
| 317 | Ubiquitination | LCTGTGSKAWSFNIN ECCCCCCCHHEEEHH | - | ||
| 317 | Succinylation | LCTGTGSKAWSFNIN ECCCCCCCHHEEEHH | - | ||
| 317 | Succinylation | LCTGTGSKAWSFNIN ECCCCCCCHHEEEHH | - | ||
| 317 | Acetylation | LCTGTGSKAWSFNIN ECCCCCCCHHEEEHH | 26051181 | ||
| 339 | Acetylation | EDVLNIAKRQGNLSL HHHHHHHHHCCCCCC | 25953088 | ||
| 339 (in isoform 1) | Ubiquitination | - | 21890473 | ||
| 339 | Ubiquitination | EDVLNIAKRQGNLSL HHHHHHHHHCCCCCC | 2190698 | ||
| 345 | Phosphorylation | AKRQGNLSLPLNREL HHHCCCCCCCCCHHH | 24275569 | ||
| 355 | Ubiquitination | LNRELVEKVTNEYNE CCHHHHHHHHHHCCH | - | ||
| 357 | Phosphorylation | RELVEKVTNEYNESL HHHHHHHHHHCCHHC | 26074081 | ||
| 360 | Phosphorylation | VEKVTNEYNESLLYS HHHHHHHCCHHCCCC | 26074081 | ||
| 363 | Phosphorylation | VTNEYNESLLYSPEE HHHHCCHHCCCCCCC | 28387310 | ||
| 366 | Phosphorylation | EYNESLLYSPEEPKI HCCHHCCCCCCCCCE | 26074081 | ||
| 367 | Phosphorylation | YNESLLYSPEEPKIL CCHHCCCCCCCCCEE | 25159151 | ||
| 372 | Ubiquitination | LYSPEEPKILFSIRE CCCCCCCCEEEEECH | - | ||
| 376 | Phosphorylation | EEPKILFSIREPIAN CCCCEEEEECHHHHH | - | ||
| 384 | Methylation | IREPIANRVFSSSRQ ECHHHHHCCCCCCCC | 115484427 | ||
| 389 | Phosphorylation | ANRVFSSSRQRCFSS HHCCCCCCCCHHHCC | 24719451 | ||
| 393 | S-nitrosocysteine | FSSSRQRCFSSKVCV CCCCCCHHHCCCCCH | - | ||
| 397 | Acetylation | RQRCFSSKVCVRSRC CCHHHCCCCCHHHCC | 25825284 | ||
| 431 | Acetylation | IASMMINKEDELRTV EEHHEECCHHHHHHH | 26051181 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NAKD2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NAKD2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NAKD2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NPTX1_HUMAN | NPTX1 | physical | 22939629 | |
| I2BPL_HUMAN | IRF2BPL | physical | 22939629 | |
| FERM2_HUMAN | FERMT2 | physical | 22939629 | |
| THTM_HUMAN | MPST | physical | 22939629 | |
| TM189_HUMAN | TMEM189 | physical | 22939629 | |
| DYL1_HUMAN | DYNLL1 | physical | 22939629 | |
| PNPH_HUMAN | PNP | physical | 22939629 | |
| STMN1_HUMAN | STMN1 | physical | 22939629 | |
| ERMAP_HUMAN | ERMAP | physical | 22939629 | |
| HTRA2_HUMAN | HTRA2 | physical | 22939629 | |
| TIM9_HUMAN | TIMM9 | physical | 22939629 | |
| TM177_HUMAN | TMEM177 | physical | 22939629 | |
| VPS29_HUMAN | VPS29 | physical | 22939629 | |
| DJB11_HUMAN | DNAJB11 | physical | 22939629 | |
| SUCB1_HUMAN | SUCLA2 | physical | 22939629 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 616034 | 2,4-dienoyl-CoA reductase deficiency (DECRD) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...